AI Assistant
Blog
Pricing
Log In
Sign Up
MP46-20 COST-EFFECTIVENESS OF SELECTMDX FOR PROSTATE CANCER IN FOUR EUROPEAN COUNTRIES: A MODELLING STUDY
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
